Clinical Roundup UAB’s Cancer Center, GO2 Foundation for Lung Cancer initiate STRIDES study to increase African American participation in lung cancer trials March 19, 2021Vol.47 No.11
Clinical Roundup New targeted agent achieves nearly 30% response rate in trial with patients with uterine serous carcinoma March 19, 2021Vol.47 No.11
Drugs & Targets CYNK-001 receives Fast Track designation from FDA for recurrent glioblastoma multiforme March 19, 2021Vol.47 No.11
Drugs & Targets Geneseeq, Illumina to develop and commercialize comprehensive cancer in-vitro diagnostic NGS kit in China March 19, 2021Vol.47 No.11
Drugs & Targets CD&R, Merck GHI, and McKesson Ventures invest oncology data and informatics company M2Gen March 19, 2021Vol.47 No.11
Three-day ODAC to review data from confirmatory trials of PD-1/PD-L1 drugs marketed under accelerated approval March 12, 2021Vol.47 No.10By Paul Goldberg
Conversation with The Cancer Letter Working in concert with NCI’s $500M data federation in childhood cancer, St. Jude demonstrates utility of its genomic database March 12, 2021Vol.47 No.10By Matthew Bin Han Ong
In Brief Xiongbin Lu named co-program leader of EDT research program at IU Simon March 12, 2021Vol.47 No.10
In Brief Regina Bou Puerto, Mijin Kim named 2021 Kravis Women in Science Endeavor fellowship grant recipients March 12, 2021Vol.47 No.10
